Evidence-based medicine and the governance of pandemic influenza

Global Public Health

Volumn 7, Issue SUPPL. 2, 2012, Pages

  Kamradt Scott, Adam ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

evidence based medicine; global health; pandemic influenza; vaccines; virus sharing

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; AVIAN INFLUENZA VIRUS; EVIDENCE BASED MEDICINE; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; KNOWLEDGE; MEDICAL INFORMATION; PANDEMIC INFLUENZA; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

ANTIVIRAL AGENTS; DEVELOPING COUNTRIES; EVIDENCE-BASED MEDICINE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PANDEMICS; WORLD HEALTH;

EID: 84870988036     PISSN: 17441692     EISSN: 17441706     Source Type: Journal    
DOI: 10.1080/17441692.2012.728239     Document Type: Article

References (76)

1. Boswell, C. 2009. The political uses of expert knowledge: immigration policy and social research, Cambridge: Cambridge University Press.
2. Brown, K.F., Kroll, J.S., Hudson, M.J., Ramsay, M., Green, J., Vincent, C.A., Fraser, G. and Sevdalis, N. 2010. Omission bias and vaccine rejection by parents of healthy children: implications for the influenza A/H1N1 vaccination programme. Vaccine, 28(25): 4181-4185.
3. Cohen, J. and Enserink, M. 2009. As swine flu circles globe, scientists grapple with basic questions. Science, 324(5927): 572-573.
4. Collin, N., Radiguès, X., and WHO H1N1 Vaccine Task Force, 2009. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine, 27 38, 5184-5186.
5. Davidoff, F., Haynes, B., Sackett, D. and Smith, R. 1995. Evidence based medicine. British Medical Journal, 310(6987): 1085-1086.
6. Denny, K. 1999. Evidence-based medicine and medical authority. Journal of Medical Humanities, 20(4): 247-263.
7. Department of Health (UK), 2011. Scientific pandemic influenza advisory committee (SPI) [online]. Available from: http://www.dh.gov.uk/ab/SPI/DH_095670 [Accessed 16 September 2011].
8. Dobbie, A.E., Schneider, D.F., Anderson, A.D. and Littlefield, J. 2000. What evidence supports teaching evidence-based medicine?. Academic Medicine, 75(12): 1184-1185.
9. Dutta, A. 2008. The effectiveness of policies to control a human influenza pandemic: a literature review Policy research working paper 4524, Washington, DC: World Bank.
10. Elbe, S. 2011. Pandemics on the radar screen: health security, infectious disease and the medicalisation of insecurity. Political Studies, 59(4): 848-866.
11. Fedson, D. 2009. Meeting the challenge of influenza pandemic preparedness in developing countries. Emerging Infectious Diseases, 15(3): 365-371.
12. Ferguson, N.M., Cummings, D.A., Fraser, C., Cajka, J.C., Cooley, P.C. and Burke, D.S. 2006. Strategies for mitigating an influenza pandemic. Nature, 442(7101): 448-452.
13. Fidler, D. 2010. Negotiating equitable access to influenza vaccines: global health diplomacy and the controversies surrounding avian influenza H5N1 and pandemic influenza H1N1. Public Library of Science Medicine, 7(5): 1-4.
14. Francis, T. 1947. A consideration of vaccination against influenza. The Milbank Memorial Fund Quarterly, 25(1): 5-10.
15. Fraser, C., Donnelly, C.A., Cauchemez, S., Hanage, W.P., Van Kerkhove, M.D., Hollingsworth, D.T., Griffin, J., Baggaley, R.F., Jenkins, H.E., Lyons, E.J., Jombart, T., Hinsley, W.R., Grassly, N.C., Balloux, F., Ghani, A.C., Ferguson, N.M., Rambaut, A., Pybus, O.G., Lopez-Gatell, H., Alpuche-Aranda, C.M., Bojorquez Chapela, L., Palacios Zavala, E., Espejo Guevara, D.M., Checchi, F., Garcia, E., Hugonnet, S., Roth, C. and Rapid Pandemic Assessment Collaboration, WHO. 2009. Pandemic potential of a strain of influenza A (H1N1): early findings. Science, 324(5934): 1557-1561.
16. Gallaher, W., 2009. Towards a sane and rational approach to management of Influenza H1N1 2009 [online]. Available from: http://www.virologyj.com/content/6/1/51 [Accessed 14 December 2011].
17. Goldenberg, M. 2006. On evidence and evidence-based medicine: lessons from the philosophy of science. Social Science and Medicine, 62(11): 2621-2632.
18. Gostin, L.O. 2006. Medical countermeasures for pandemic influenza: ethics and the law. Journal of the American Medical Association, 295(5): 554-556.
19. GSK, 2007. New studies indicate GSK's pre-pandemic influenza vaccine can protect against different strains of H5N1 [online]. Available from: http://www.gsk.com/media/pressreleases/2007/2007_03_05_GSK989.htm [Accessed 16 September 2011].
20. Haas, E.B. 1990. When knowledge is power: three models of change in international organizations, London: University of California Press.
21. Hayden, F.G. 1997. Antivirals for pandemic influenza. Journal of Infectious Diseases, 176(Suppl. 1): S56-S61.
22. Hota, S. and McGeer, A. 2007. Antivirals and the control of influenza outbreaks. Clinical Infectious Diseases, 45(10): 1362-1368.
23. IMF, 2006. The global economic and financial impact of an avian flu pandemic and the role of the IMF [online]. Washington, DC: International Monetary Fund. Available from: http://www.imf.org/external/pubs/ft/afp/2006/eng/022806.pdf [Accessed 24 February 2011].
24. Jack, A. 2009. Flu's unexpected bonus. British Medical Journal, 339: b3811
25. Jensen, K. and Hogan, R. 1958. Laboratory diagnosis of Asian influenza. Public Health Reports (1896-1970), 73(2): 140-144.
26. Kamradt-Scott, A. 2012. Changing perceptions of pandemic influenza and public health responses. American Journal of Public Health Policy, 102(1): 90-98.
27. Kamradt-Scott, A., forthcoming. The politics of medicine and the global governance of pandemic influenza. International Journal of Health Services.
28. Kamradt-Scott, A. and Lee, K. 2011. The 2011 pandemic influenza preparedness framework: global health secured or a missed opportunity?. Political Studies, 59(4): 831-847.
29. Kelso, J., Milne, G., and Kelly, H., 2009. Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of influenza [online]. Available from: http://www.biomedcentral.com/1471-2458/9/117 [Accessed 25 February 2011].
30. Kitler, M., Gavinio, P. and Lavanchy, D. 2002. Influenza and the work of the World Health Organization. Vaccine, 20(Suppl. 2): S5-S14.
31. Kristiansen, I.S. and Mooney, G. 2004. "Evidence-based medicine: method, collaboration, movement or crusade?". In Evidence-based medicine: in its place, Edited by: Kristiansen, I.S. and Mooney, G. 1-19. Abingdon: Routledge. (Chapter 1)
32. Lawrence, R.G. 2000. Game-framing the issues: tracking the strategy frame in public policy news. Political Communication, 17: 93-114.
33. Laver, G. 2005. Influenza drug could abort a pandemic. Nature, 434(7035): 821
34. Lederberg, J. 1996. Infectious disease-a threat to global health and security. Journal of the American Medical Association, 276(5): 417-419.
35. Longini, I.M., Halloran, M.E., Nizam, A. and Yang, Y. 2004. Containing pandemic influenza with antiviral agents. American Journal of Epidemiology, 159(7): 623-633.
36. MacPhail, T. 2009. The politics of bird flu: the battle over virus samples and China's role in global public health. Journal of Language and Politics, 8(3): 456-475.
37. Marston, G. and Watts, R. 2003. Tampering with the evidence: a critical appraisal of evidence-based policy-making. The Drawing Board: An Australian Review of Public Affairs, 3(3): 143-163.
38. Monto, A.S. 1997. Prospects for pandemic influenza control with currently available vaccines and antivirals. Journal of Infectious Diseases, 176(Suppl. 1): S32-S37.
39. Monto, A.S. 2006. Vaccines and antiviral drugs in pandemic preparedness. Emerging Infectious Diseases, 12(1): 55-60.
40. Mykhalovskiy, E. and Weir, L. 2004. The problem of evidence-based medicine: directions for social science. Social Science and Medicine, 59(5): 1059-1069.
41. Nelson, T.E. and Oxley, Z.M. 1999. Issue framing effects on belief importance and opinion. Journal of Politics, 61(4): 1040-1067.
42. Nichol, K., Lind, A., Margolis, K., Murdoch, M., McFadden, R., Hauge, R., Magnan, S. and Drake, M. 1995. The effectiveness of vaccination against influenza in healthy, working adults. New England Journal of Medicine, 333(14): 889-893.
43. Oshitani, H., Kamigaki, T. and Suzuki, A. 2008. Major issues and challenges of influenza pandemic preparedness in developing countries. Emerging Infectious Diseases, 14(6): 875-880.
44. Payne, A. 1953. The influenza programme of WHO. Bulletin of the World Health Organization, 8(5-6): 755-792.
45. Pereira, M.S. 1979. Global surveillance of influenza. British Medical Bulletin, 35(1): 9-14.
46. Pope, C. 2003. Resisting evidence: the study of evidence-based medicine as a contemporary social movement. Health, 7(3): 267-282.
47. Ruben, F., 1987. Prevention and control of influenza: role of vaccine. American Journal of Medicine, 82 6 (Suppl. 1), 31-34.
48. Sackett, D. and Rosenberg, W. 1995. The need for evidence-based medicine. Journal of the Royal Society for Medicine, 88: 620-624.
49. Sedyaningsih, E.R., Isfandari, S., Soendoro, T. and Supari, S.F. 2008. Towards mutual trust, transparency and equity in virus sharing mechanism: the avian influenza case of Indonesia. Annals Academy of Medicine, 37(6): 482-488.
50. Sheridan, C. 2005. The business of making vaccines. Nature Biotechnology, 23(11): 1359-1366.
51. Shuchman, M. 2007. Improving global health-Margaret Chan at the WHO. New England Journal of Medicine, 356(7): 653-656.
52. Smith, A. 1996. Mad cows and ecstasy: chance and choice in an evidence-based society. Journal of the Royal Statistical Society: Series A, 159(3): 367-383.
53. Snacken, R., Kendal, A., Haaheim, L. and Wood, J. 1999. The next influenza pandemic: lessons from Hong Kong, 1997. Emerging Infectious Diseases, 5(2): 195-203.
54. Steelfischer, G.K., Blendon, R.J., Bekheit, M.M. and Lubell, K. 2010. The public's response to the 2009 H1N1 influenza pandemic. New England Journal of Medicine, 362(22): 65
55. Stiver, G. 2003. The treatment of influenza with antiviral drugs. Canadian Medical Association Journal, 168(1): 49-56.
56. Stöhr, K. 2003. The global agenda on influenza surveillance and control. Vaccine, 21(16): 1744-1748.
57. Tay, J., Ng, Y.F., Cutter, J. and James, L. 2010. Influenza A (H1N1-2009) pandemic in Singapore-public health control measures implemented and lessons learnt. Annals Academy of Medicine Singapore, 39(4): 313-324.
58. Third World Network, 2007. Winners and losers in the sharing of avian flu viruses [online]. Available from: http://www.twnside.org.sg/title2/intellectual_property/info.service/twn.ipr.info.050705.htm [Accessed 16 September 2011].
59. Tonelli, M. 1998. The philosophical limits of evidence-based medicine. Academic Medicine, 73(12): 1234-1240.
60. UNSIC and World Bank, 2008. Responses to avian influenza and state of pandemic readiness. Third global progress report, December 2007 New York: United Nations System Influenza Coordination.
61. UNSIC and World Bank. 2010. Animal and pandemic influenza: a framework for sustaining momentum. Fifth global progress report, July 2010. New York: United Nations System Influenza Coordination.
62. Vandermeer, M., Thomas, A., Kamimoto, K., Reingold, A., Gershman, K., Meek, J., Farley, M., Ryan, P., Lynfield, R., Baumbach, J., Schaffner, W., Bennett, N. and Zansky, S. 2012. Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study. Journal of Infectious Diseases, 205(1): 13-19.
63. Ward, P., Small, I., Smith, J., Suter, P., and Dutkowski, R., 2005. Osteltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic. Journal of Antimicrobial Chemotherapy, 55 (Suppl. 1), i5-i121.
64. Webster, R. 1994. While awaiting the next pandemic of influenza. British Medical Journal, 309(6063): 1179
65. Webster, R. and Kawaoka, Y. 1994. Influenza-an emerging and re-emerging disease. Virology, 5(2): 103-111.
66. Wilkinson, K. 2011. Organised chaos: an interpretive approach to evidence-based policy making in Defra. Political Studies, 59(4): 959-977.
67. WHO, 1988. Consultation with directors of WHO collaborating centres on influenza: memorandum from a WHO meeting. Bulletin of the World Health Organization, 66 4, 457-458.
68. WHO, 1994. Emerging infectious diseases: memorandum from a WHO meeting. Bulletin of the World Health Organization, 72 6, 845-850.
69. WHO, 1999. Influenza pandemic preparedness plan: the role of WHO and guidelines for national and regional planning, Geneva, Switzerland, April 1999. Geneva: World Health Organization.
70. WHO, 2004. WHO influenza pandemic preparedness checklist [online]. Geneva: World Health Organization. Available from: http://www.wpro.who.int/internet/resources.ashx/CSR/Publications/WHO+Influenza+Pandemic+Preparedness+Checklist.pdf [Accessed 24 February 2011].
71. WHO, 2005a. Avian influenza: assessing the pandemic threat [online]. Geneva: World Health Organization. Available from: http://www.who.int/csr/disease/influenza/H5N1-9reduit.pdf [Accessed 22 February 2011].
72. WHO, 2005b. WHO global influenza preparedness plan: the role of WHO and recommendations for national measures before and during pandemics [online]. Geneva: World Health Organization. Available from: http://whqlibdoc.who.int/hq/2005/WHO_CDS_CSR_GIP_2005.5.pdf [Accessed 1 December 2011].
73. WHO, 2005c. WHO checklist for influenza pandemic preparedness planning [online]. Geneva: World Health Organization. Available from: http://www.who.int/csr/resources/publications/influenza/FluCheck6web.pdf [Accessed 25 February 2011].
74. WHO. 2009. Pandemic influenza preparedness and response: a WHO guidance document [online]. Geneva: World Health Organization. Available from: http://www.who.int/influenza/resources/documents/pandemic_guidance_04_2009/en/index.html [Accessed 2 May 2012].
75. WHO, 2011a. WHO global influenza surveillance network [online]. Available from: http://www.who.int/csr/disease/influenza/surveillance/en/index.html [Accessed 18 February 2011].
76. WHO, 2011b. Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits [online]. Available from: www.who.int/csr/disease/influenza/pip_framework_16_april_2011.pdf [Accessed 11 September 2011].